Alzheimer's ex­perts call on FDA to pull Bio­gen's Aduhelm

Alzheimer’s dis­ease re­searchers along with med­ical pro­fes­sors from Har­vard and Johns Hop­kins is­sued a for­mal state­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA